AOD 9604 Peptide Dose: What Research Protocols Actually Use

The typical AOD 9604 peptide dose described in research settings is 250 to 500 micrograms (mcg) per day, given as a subcutaneous injection, usually in the morning while fasted. Some protocols use 300 mcg once daily, while others split the amount into two smaller shots or push toward 1 mg per day. AOD-9604 is not FDA-approved for human use in the United States, so these figures come from laboratory data and community reporting rather than an approved prescribing label.

What AOD-9604 Is and Why the Dose Is Measured in Micrograms

AOD-9604 is a synthetic 16-amino-acid fragment of human growth hormone, matching the region of HGH known as amino acids 176-191. Researchers modified that fragment to isolate the fat-metabolizing portion of HGH while avoiding its effects on blood sugar and growth signaling.

Because the peptide is small and clears quickly, doses are measured in micrograms rather than milligrams. AOD-9604 has a reported half-life of roughly 30 minutes after injection, which is why most protocols call for daily or twice-daily administration instead of weekly dosing.

AOD-9604 is sold as a research chemical labeled "for laboratory use only," and it is not approved as a drug for weight loss, athletic performance, or any other human condition.

Common AOD 9604 Dose Ranges

Reported doses vary widely, but they cluster into a few recognizable bands. The table below summarizes what appears most often in research summaries and user-reported logs.

Dose band	Amount per injection	Frequency	Typical notes
Low / conservative	100-200 mcg	Once daily	Often used as a starting point
Standard	250-500 mcg	Once daily	Most commonly referenced range
Higher	500 mcg-1 mg	Once or split into two	Less common; larger injection volume
Cycled	Same daily amount	5 days on, 2 days off	Used to limit cost and cumulative exposure

Most research and community protocols settle around 300 mcg per day, and doses above 500 mcg per day are not clearly supported by published human data.

How Often and When to Take AOD 9604

Frequency is usually daily. A common research schedule is one injection each morning, 20 to 30 minutes before eating, based on the idea that fasting and low insulin levels support fat mobilization.

Some users split the total into two injections, morning and early evening, spaced 8 to 12 hours apart. Others follow a five-days-on, two-days-off pattern. The question of how often do you take aod 9604 rarely has one correct answer, because no regulatory body has published an approved schedule.

Timing around training is another frequent talking point, since many people discuss when to take aod 9604 peptide in relation to fasted cardio or resistance sessions. There is no strong clinical evidence that pre-workout timing changes outcomes, and consistency matters more than hitting a perfect window.

How to Use AOD-9604: Injection and Reconstitution Basics

Anyone asking how to use aod 9604 peptide should understand the basic math first. If a 2 mg vial is reconstituted with 2 mL of bacteriostatic water, the concentration becomes 1 mg per mL, so a 250 mcg dose equals 0.25 mL, or 25 units on a U-100 insulin syringe.

Reconstitute gently. Add the water slowly down the inside wall of the vial, then swirl rather than shake. Shaking damages peptide structure and creates foam that makes accurate drawing harder.

Why AOD-9604 Gels Up

AOD-9604 is a hydrophobic peptide, meaning it prefers to clump away from water. The topic of aod-9604 gelling up comes up constantly because the peptide can form a cloudy gel when it is mixed too fast, mixed too cold, or mixed at a very high concentration.

• Let the bacteriostatic water reach room temperature before mixing.
• Add water in a slow, steady stream against the glass wall.
• Swirl gently; never shake the vial.
• If a gel forms, add a larger volume of water and let the vial sit at room temperature for 10 to 15 minutes.

Once mixed, refrigerate the solution at 2-8 degrees Celsius and protect it from light. Keep the lyophilized powder frozen until you are ready to use it.

AOD 9604 vs MOTS-c: Dosing Differences

These two peptides are frequently compared, but they operate on completely different dose scales. MOTS-c is a mitochondrial-derived peptide studied for metabolic effects, and research protocols typically describe milligrams per week rather than micrograms per day.

Feature	AOD-9604	MOTS-c
Origin	HGH fragment 176-191	Mitochondrial-derived peptide
Common research dose	250-500 mcg per day	5-10 mg per week, often split
Typical frequency	Daily or twice daily	2-3 injections per week
Reported half-life	About 30 minutes	Not well established
Primary research focus	Fat metabolism	Metabolic and mitochondrial function
FDA status	Not approved for human use	Not approved for human use

The practical takeaway from any aod 9604 vs mots-c comparison is that a "typical dose" is not transferable between the two peptides. They differ in size, clearance, and the total mass of compound used per injection.

Safety, Side Effects, and Legal Status

AOD-9604 has been examined in small human trials for obesity and osteoarthritis, but it has never received FDA approval for any indication. Products sold online are almost always labeled "not for human consumption."

Reported side effects are generally mild and include redness or soreness at the injection site, headache, and fatigue. Long-term human safety data are limited, and injecting a non-sterile or mislabeled product carries real risks of infection and contamination.

• Avoid use during pregnancy or breastfeeding.
• Talk with a licensed healthcare professional before using any research peptide.
• Athletes should check current WADA and sport-specific rules, since peptide statuses change over time.
• Never share needles or reuse injection supplies.

Sourcing, Purity, and What to Verify

When evaluating a supplier, purity and documentation matter far more than price. A reputable research vendor provides a batch-specific certificate of analysis from an independent lab showing HPLC purity and mass spectrometry confirmation.

General online marketplaces rarely meet that bar. Listings on large retail sites often carry vague labels, no third-party certificate of analysis, and "not for human use" disclaimers, which makes verifying peptide identity and sterility nearly impossible.

Storing reconstituted solution in a refrigerator and the dry powder in a freezer slows degradation. If a properly mixed solution turns cloudy or shows visible particles, discard it.

COMMON QUESTIONS

Frequently Asked Questions

What is the typical AOD 9604 peptide dose?

There is no FDA-approved human dose, so no official recommendation exists. Research and community protocols most often describe 250 to 500 mcg injected subcutaneously once daily, with 300 mcg as a commonly cited middle figure. Anyone considering it should review the risks with a licensed healthcare professional first.

How long does AOD-9604 stay in your system?

The reported half-life of AOD-9604 is roughly 30 minutes after a subcutaneous injection. That short clearance time is the main reason most protocols use daily or twice-daily dosing rather than weekly injections. Downstream metabolic effects may last longer than the peptide itself.

Why does AOD-9604 gel up when it is reconstituted?

AOD-9604 is a hydrophobic peptide, so it can clump into a cloudy gel when it contacts water too quickly, too cold, or at a high concentration. Using room-temperature bacteriostatic water, adding it slowly down the vial wall, and swirling instead of shaking usually prevents the problem.